Live COVID-19 Cases
  • World 244,159,184
    Confirmed: 244,159,184
    Active: 17,982,570
    Recovered: 221,216,627
    Death: 4,959,987
  • USA 46,294,210
    Confirmed: 46,294,210
    Active: 9,504,119
    Recovered: 36,033,886
    Death: 756,205
  • India 34,175,468
    Confirmed: 34,175,468
    Active: 172,562
    Recovered: 33,548,605
    Death: 454,301
  • Brazil 21,723,559
    Confirmed: 21,723,559
    Active: 222,104
    Recovered: 20,895,886
    Death: 605,569
  • UK 8,734,934
    Confirmed: 8,734,934
    Active: 1,479,294
    Recovered: 7,116,179
    Death: 139,461
  • Russia 8,205,983
    Confirmed: 8,205,983
    Active: 833,318
    Recovered: 7,143,137
    Death: 229,528
  • France 7,120,863
    Confirmed: 7,120,863
    Active: 93,804
    Recovered: 6,909,596
    Death: 117,463
  • Spain 4,997,732
    Confirmed: 4,997,732
    Active: 62,168
    Recovered: 4,848,432
    Death: 87,132
  • Italy 4,737,462
    Confirmed: 4,737,462
    Active: 74,016
    Recovered: 4,531,644
    Death: 131,802
  • Germany 4,464,667
    Confirmed: 4,464,667
    Active: 162,473
    Recovered: 4,206,400
    Death: 95,794
  • China 96,758
    Confirmed: 96,758
    Active: 564
    Recovered: 91,558
    Death: 4,636
Generic selectors
Exact matches only
Search in title
Search in content
Generic selectors
Exact matches only
Search in title
Search in content
open access symbol

BY Leo Hynett


RwHealth Rumoured to Be Preparing IPO Worth £100m

Reports suggest that Realworld Health is preparing to list on the junior stock market and is targeting a valuation of £100m when it does.



London-based RwHealth is rumoured to have hired brokers from Finncap to prepare an initial public offering and list on the junior stock market. Sky News reports that RwHealth is expected to target a £100million plus valuation when it lists during the first quarter of next year.

The firm, which specialises in Artificial Intelligence, works alongside numerous leading hospitals in the NHS. Through the application of AI in the NHS, RwHealth has developed software which can learn to anticipate patient flows and drive cost-improvement programmes.

At the helm is a man well versed in the healthcare sector, Orlando Agrippa, who boasts over a decade of experience working in numerous positions across National Health Services. His newest venture could be his most successful yet, as RwHealth’s Data Science Platform (DSP) continues to improve the way that healthcare works.

The current Coronavirus Pandemic has only emphasised the pressures faced by the world’s health services, and the news of RwHealth’s potential IPO has arrived in the midst of a debate about private companies in the NHS. The backlog of patients waiting for treatment, increasing scarcity of available hospital beds, dwindling resources, and ever-present number of COVID cases have all highlighted the need to streamline processes in healthcare.

While RwHealth did not comment on the prospective flotation next year, the company has frequently reiterated its commitment to address ongoing crises in healthcare. Mr Agrippa writes:

‘Now, more than a year on from the first realisations of the true impact Covid-19 was to have across the globe, the time to address what is not just a crisis born of the effects of a virus of this magnitude, but also of a wider spread healthcare challenge, is more urgent than ever.’

RwHealth’s software is currently in use across several NHS trusts and large pharmaceutical companies and the ongoing healthcare crisis is suggestive that soon, the reach of this company will increase as more hospitals attempt to improve their patient flows.

The news that RwHealth is potentially listing on the junior stock market next year is exciting, and should news follow that the company has succeeded in receiving a £100million plus valuation, few should be surprised. The future is uncertain as the world continues to fend off COVID-19, but the future of healthcare will most certainly include the AI systems from companies like RwHealth.

Recommended for you

What is COP26 and Why Does it Matter?

The COP26 climate summit is on the horizon, but what exactly will it entail? Who is attending? And perhaps more importantly, who isn’t?